Impact of Dysphagia Therapy in Parkinson’s Disease | ||||
The Egyptian Journal of Hospital Medicine | ||||
Article 14, Volume 69, Issue 4, October 2017, Page 2258-2265 PDF (580.13 K) | ||||
Document Type: Original Article | ||||
DOI: 10.12816/0041527 | ||||
View on SCiNiTO | ||||
Authors | ||||
Faisal Ahmed M. Abu Shaigah1; Ahlammohammed Zabbani2; Alya Bakr A. Qadi3; Abdulrahman Mohammed M Aloufi4; Anmar Ahmed T Sultan5; Hussain Abdullah Aljuwayd6; Ahmed Ali H Ghawas7; Ahmed Mohammed Alawadh8; Fayezaemadaldeen Alam9; Mohammed Abdullah Alghamdi9; Reem Salem M Alenzi10; Fatimah Nader Al Jish11 | ||||
1Dammam Medical Complex | ||||
2Batterjee Medical College | ||||
3Medical University of Lodz | ||||
4King Khalid University | ||||
5King Salman Hospital | ||||
6Maastricht University, Netherlands | ||||
7King Faisal University | ||||
8Arabian Gulf University | ||||
9King Abdulaziz University | ||||
10Northern Border University | ||||
11Qatief Central Hospital | ||||
Abstract | ||||
Background: Dysphagia is a common symptom in Parkinson's disease (PD) which indicates a difficulty in swallowing. It has been accompanied with poor quality of life (QoL), anxiety and depression. Aim of the Study: to assess the effects of dysphagia treatment in Parkinson’s disease. Materials and methods: Studies published up to July 2017 were found via a systematic comprehensive electronic database search using PubMed, Embase, and The Cochrane Library.Two reviewers independently assessed the studies using strict inclusion criteria. Results: Thirteen studies were enrolled in the present study and qualitatively analyzed using critical appraisal items. The review includes rehabilitative (exercises, electrical stimulation, bolus modification etc.) and pharmacologic treatment. Some well-designed controlled trials were included. However, none of the included studies fulfilled all criteria for external and internal validity. Thus, a meta-analysis was not carried out as most of the studies were not of sufficient quality. Conclusion: Rehabilitative treatment including Expiratory Muscle Strength Training (EMST) may be effective for dysphagia treatment solely coupled with dopaminergic therapy for PD. Recently developed other treatment methods such as implant-prosthodontic treatment and percutaneous injection of botulinum neurotoxin type A in the cricopharyngeal muscle on dysphagia is rather promising. Nevertheless, these preliminary results warrant further investigation concerning their clinical applicability, and further research should be conducted. | ||||
Keywords | ||||
Dysphagia; Swallowing disorder, Parkinson's disease, Therapy outcome | ||||
Statistics Article View: 280 PDF Download: 409 |
||||